Skip to main content

Advertisement

Log in

Treating schizophrenia earlier in life and the potential for prevention

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Early detection and intervention in schizophrenia has captured increasing attention of clinicians and clinical researchers in the past decade. It has obvious public health value for active first psychosis but it also holds potential for changing the course of disorder in ways that supercede symptom control. The research bearing upon the early phase of disorder, especially that presented recently at the March/April 2000 meeting of The International Early Psychosis Association in New York, is reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. McGlashan TH, Johannessen JO: Early detection and intervention with schizophrenia: rationale. Schizophr Bull 1996, 22:201–222.

    PubMed  CAS  Google Scholar 

  2. McGlashan TH, Hoffman RE: Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry, in press.

  3. McGlashan TH: Early detection and intervention in schizophrenia: editor’s introduction. Schizophr Bull 1996, 22(2):197–199.

    PubMed  CAS  Google Scholar 

  4. McGorry P: Preventive strategies in early psychosis: verging on reality. Br J Psychiatry 1998, 172(suppl 33):1–2.

    CAS  Google Scholar 

  5. McGlashan TH: Duration of untreated psychosis in firstepisode schizophrenia: marker or determinant of course? Biol Psychiatry 1999, 46:899–907. A useful review of the data, meaning, issues and questions regarding this new descriptor of the course of psychosis

    Article  PubMed  CAS  Google Scholar 

  6. Friis S: Threats to the validity of multi-site, longitudinal studies of first-episode schizophrenia. Presentation at the International Congress on Schizophrenia Research. Santa Fe, NM:April 19, 1999.

  7. Craig TJ, Bromet EJ, Fennig S, et al.: Is there an association between duration of untreated psychosis and 24-month clinical outcome in first-admission series? Am J Psychiatry 2000, 157:60–66. A well executed non-replication of the association of long DUP and poor prognosis.

    PubMed  CAS  Google Scholar 

  8. Beng-Choon H, Andreasen NC, Flaum M, et al.: Untreated I initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000, 157:808–815.

    Article  Google Scholar 

  9. Croudace TJ: Prognostic significance of the duration of untreated psychosis. Presentations at the Second international Conference on Early Psychosis. April 1, 2000, New York, NY.

  10. Carbone S, Harrigan S, McGorry PD, et al.: Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand 1999, 100:96–104.

    PubMed  CAS  Google Scholar 

  11. Harrigan SM, McGorry PD, Kristev H: Does treatment delay in first-episode psychosis really matter? Presentation at the Second International Conference on Early Psychosis. New York, NY: March 31, 2000.

  12. Larsen TK: First-episode schizophrenia; Reducing delays in treatment. Presentation at the Second International Conference on Early Psychosis. New York, NY: March 30, 2000.

  13. Vaglum P, Lasen TK, Friis S, et al.: Are long DUP patients different when readmitted in an early detection system compared with a detection system as usual? Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  14. Goldman RS, Bates J, Bilder RM, et al.: Neurocognitive recovery in schizophrenia. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  15. Bates J, Goldman RS, Bilder RM, et al.: Long-term longitudinal assessment of neurocognition in first-episode schizophrenia. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  16. Joyce EM, Hutton SB, Ambery FZ, et al.: The nature of executive function early in the course of schizophrenia: the west London first-episode schizophrenia study. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  17. Norman R, Malla A, Townsend L: Duration of untreated psychosis and neurocognitive functioning in first-episode patients. Presentation at the Second International Conference on Early Psychosis. New York, NY: March 31, 2000.

  18. Friis S, Rund B, Sundet K, et al.: Neurocognitive functioning patients with first episode psychosis. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  19. Marcus J, Hans SL, Auerbach JG, Auerbach AG: Children at risk for schizophrenia: the Jerusalem infant development study. II. Neurobehavioral deficits at school age. Arch Gen Psychiatry 1993, 50:797–809.

    PubMed  CAS  Google Scholar 

  20. Jones P, Rodgers B, Murray R, Marmot M: Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994, 344:1398–1402.

    Article  PubMed  CAS  Google Scholar 

  21. Jones P, Van Oss JJ: Predicting schizophrenia in teenagers: pessimistic results from the British 1946 birth cohort. Presentation at the Sixth International Conference on Schizophrenia Research. Colorado Springs, CO: April 1997.

  22. Cornblatt B: Vulnerability markers in the premorbid phase. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  23. Keshavan MS, Zeigler M, Montrose D, Spencer S, et al.: Frontotemporal integrity in children and adolescent offspring at risk for schizophrenia. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 2, 2000.

  24. Davidson M, Reichenberg MA, Rabinowitz J, et al.: Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 1999, 156:1328–1335. A pivotal study showing substantial premorbid deficits in adolescent males that are strong predictors of psychosis formation years later.

    PubMed  CAS  Google Scholar 

  25. Davidson M: Premorbid predictors of schizophrenia in late adolescence. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  26. Klosterkotter J: Huber’s basic symptoms: a German approach to the initial prodrome of schizophrenia. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  27. Moller P, Husby R: The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behaviour: an explanatory case study beyond preconstructed symptom lists. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  28. Hafner H: Prodromal phase and early course of schizophrenia. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 2, 2000.

  29. Salokangas R: Predictors of transition: from prodrome to psychosis. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 2, 2000.

  30. Yung A, McGorry P: CAARMS. Personal communication, 1996.

  31. Lencz T, Pappadopoulos E, Obuchowski M, et al.: IPDE screen for the schizophrenia prodrome. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 1, 2000.

  32. Miller TJ, McGlashan TH, Woods SW, et al.: Symptom assessment in schizophrenic prodromal states. Psychiatric Q 1999, 70:273–287. Prodromal phenomenology is discussed and one of the new structured interviews for assessing the prodrome is described.

    Article  CAS  Google Scholar 

  33. McGlashan TH, Miller TJ, Woods SW: A scale for the assessment of prodromal symptoms and states. In Early Intervention In Psychiatric Disorders. Edited by Miller TJ, Mednick S, McGlashan TH, et al. The Netherlands: Kluwer Press; In press.

  34. Miller TJ: Prodromal instrumentation and early reliability. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 2, 2000.

  35. Yung A, McGorry P, McFarlane C, et al.: Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 1996, 22:283–303.

    PubMed  CAS  Google Scholar 

  36. Yung A, Phillips L, McGorry P, et al.: Prediction of psychosis. Br J Psychiatry 1998, 172(suppl 33):14–20. A very important contribution demonstrating that clinical criteria can define a prodromal sample that is at very high risk for imminent development of psychosis

    CAS  Google Scholar 

  37. McGorry P, Yung A, Phillips L: “Closing in”: What features predict the onset of first episode psychosis within a high-risk group? In The early stages of schizophrenia. Edited by Zipusky Schulz C. Washington, DC: American Psychiatric Press; In press.

  38. Velakoulis D, Brewer W, Proffitt T, et al.: Hippocampal changes over the course of psychosis: cross sectional and longitudinal MRI studies in ultra high-risk, first episode and chronic psychoses. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 2, 2000.

  39. Hawkins K: Neuropsychological markers of susceptibility in prodromal patients. Presentation at the Second International Conference on Early Psychosis. New York, NY: April 2, 2000.

  40. O’Sullivan BT, Cervantes R, Woodham B, et al.: PET imaging of vulnerable cognitive processes in schizophrenia: do early compensatory changes precede cognitive decline? Presentation at the Second International Conference on Early Psychosis. New York, NY: April 2, 2000.

  41. Glazer WM: Expected incidence of tardive dyskinesia associated with atypical antipsychotics. J Clin Psychiatry 2000, 61(suppl 4):21–26.

    PubMed  CAS  Google Scholar 

  42. McGlashan TH: Early detection and intervention in schizophrenia: research. Schizophr Bull 1996, 22:327–345.

    PubMed  CAS  Google Scholar 

  43. McGlashan TH: Early detection and intervention in schizophrenia: Rationale and research. Br J Psychiatry 1998, 172(suppl 33):3–6.

    CAS  Google Scholar 

  44. McGorry PD, Krstev H, Harrigan S: Early detection and treatment delay: implications for outcome in early psychosis. Curr Opin Psychiatry 2000, 13:37–43. This is the latest published report of the PACE Clinic prodromal early intervention clinical trial. Initial results are promising concerning prevention aims.

    Article  Google Scholar 

  45. McGorry P, Phillips L, Yung A: Recognition and treatment of the pre-psychotic phase of psychotic disorders: frontier or fantasy? In Early intervention in psychiatric disorders. Edited by Miller TJ, Mednick S, McGlashan T, et al. The Netherlands: Kluwer Press; in press.

  46. Phillips LJ, McGorry PD, Yung AR, et al.: The development of preventive interventions for early psychosis: early findings and directions for the future. Schizophrenia Res 1999, 36:331.

    Google Scholar 

  47. McGorry P: Preventative interventions in the prepsychotic phase—panacea, pipedreams or Pandora’s box? Presentation at the Second International Conference on Early Psychosis. New York, NY: April 2, 2000.

  48. Miller TJ: Identifying youth at risk before onset. Workshop presentation at the Second International Conference on Schizophrenia Research. New York, NY: April 1, 2000.

  49. Phillips L, Yung A, Hearn N, et al.: Preventive mental health care: accessing the target population. Aust N Z J Psychiatry 1999, 33:912–917.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGlashan, T.H. Treating schizophrenia earlier in life and the potential for prevention. Curr Psychiatry Rep 2, 386–392 (2000). https://doi.org/10.1007/s11920-000-0020-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-000-0020-8

Keywords

Navigation